NCT07147192

Feasibility Study of an Accommodating IOL Design

Recruiting
NAAges 22+InterventionalDevice feasibility
Alcon Research
~85 participants
Updated 2026-05-19 on ClinicalTrials.gov
What's tested:AAL-FAIOLBAL-FAIOLPhacoemulsification

At a glance

Recruiting sites
2 of 4 listed sites are recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Cumulative ocular adverse events (AEs), including Secondary Surgical Interventions (SSIs)
Measured over From Day 0 up to Month 12
Aphakia
4 sites across 4 states
Costa Rica1
Dominican Republic1
El Salvador1
Panama1
  • Clinical Trial Lead, Surgical · STUDY_DIRECTOR · Alcon Research, LLC

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Able to understand and sign an Informed Consent Form.
Willing and able to attend all scheduled study visits required per protocol.
Diagnosed with bilateral cataracts requiring removal by phacoemulsification.
Preoperative corneal astigmatism equal to or less than 1.50 diopter (D) in both eyes.

Exclusion

Women of childbearing potential who are pregnant, intend to become pregnant during the study, or are breastfeeding.
Taking medications that could increase risk or may affect accommodation.
Eye conditions as specified in the protocol, including glaucoma or ocular hypertension.
Medical conditions that could increase operative risk as specified in the protocol.
  • Cumulative ocular adverse events (AEs), including Secondary Surgical Interventions (SSIs)From Day 0 up to Month 12

    The number of adverse events, including SSI's, will be calculated. An SSI is a subsequent operation performed to address issues or complications arising from a previous surgical procedure. AEs will be collected starting at Day 0 after informed consent. SSIs will be collected starting Day 1.